3. Šuca H., Sabová J., Juhás S., Juhásová J., Jenčová V., Košťáková E.K., Sahatsapan N., Fröhlichová L., Lisenko M., Zajíček R., Vasilenko T., Lukáš D., Rejman D., Gál P. Thickness-dependent healing effects of polycaprolactone electrospun nanofiber dressings (Loaded with lipophosphonoxin) in partial-thickness skin wounds. J. Biomed Mater. Res. - B Appl. Biomater. 2026, In press.
DOI: https://doi.org/10.1002/jbm.b.70054
2. Sabová J., Bogdanová K., Večeřová R., Resová K., Mojr V., Rejman D., Gál P. Biological profiling of structurally diverse LEGO-LPPOs reveals differences in antibacterial activity, cytocompatibility, and in vivo tolerability. J. Antibiot. 2026, In press.
DOI: https://doi.org/10.1038/s41429-026-00952-w
1. Kóšiová I., Štěpánek I., Šimák O., Kostov O., Petrová M., Páv O., Rejman D., Liboska R., Buděšínský M., Rosenbergová Š., Birkuš G., Rosenberg I. Conformationally constrained phosphonate backbone linkages enhance CpG oligonucleotide activation of Toll-Like receptor 9. ACS Pharmacol. Transl. Sci. 2026, 9, 2324–2332.
DOI: https://doi.org/10.1021/acsptsci.6c00326
5. Lipophosphonoxins, method of their preparation and use. EP2527351
4. 6-Oxopurine phosphoribosyl transferase inhibitors. WO 2017100849 A1, PCT/AU2016/051238
3. Lipophosphonoxins of second generation, and their use. WO2017186200A1
2. Lipophosphonoxins, their preparation and use. EP4072681B1
1. A nanofibrous material, particularly for the topical use during therapies. CZ310151
11. Keough, D.T., Petrová, M., King, G., Kratochvíl, M., Pohl, R., Doleželová, E., Zíková, A., Guddat, L. W., Rejman, D. Development of Prolinol Containing Inhibitors of Hypoxanthine–Guanine–Xanthine Phosphoribosyltransferase: Rational Structure-Based Drug Design. J. Med. Chem. 2024 67(9), 7158-7175.
10. Do Pham, D. D., Mojr, V., Helusová, M., Mikušová, G., Pohl, R., Dávidová, E., Šanderová, H., Vítovská, D., Bogdanová, K., Večeřová, R., Sedláková, M. H., Fišer, R., Sudzinová, P., Pospíšil, J., Benada, O., Křížek, T., Galandáková, A., Kolář, M., Krásný, L., & Rejman, D. LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials. J. Med. Chem. 2022, 65 (14), 10045−10078.
9. Do Pham, D.D., Jenčová, V., Kaňuchová, M., Bayram, J., Grossová, I., Šuca, H., Urban, L., Havlíčková, K., Novotný, V., Mikeš, P., Mojr, V., Asatiani, N., Košťáková, E.K., Maixnerová, M., Vlková, A., Vítovská, D., Šanderová, H., Nemec, A., Krásný, L., Zajíček, R., Lukáš, D., Rejman, D., and Gál, P. Novel lipophosphonoxin-loaded polycaprolactone electrospun nanofiber dressing reduces Staphylococcus aureus induced wound infection in mice. Sci. Rep. 2021, 11: 17688.
7. Jimmy,S.; Saha, C.K.; Kurata, T.; Stavropoulos, C.;Oliveira, S.R.A.; Koh, A.; Cepauskas, A.; Takada, H.; Rejman, D.; Tenson, T.; Strahl, H.; Garcia-Pino, A.; Hauryliuk, V.; Atkinson, G.C.: A widespread toxin−antitoxin system exploiting growth control via alarmone signaling. PNAS USA 2020, 117 (19), 10500-10510.
6. Zborníková, E.; Knejzlík, Z.; Hauryliuk, V.; Krásný, L.; Rejman, D. Analysis of nucleotide pools in bacteria using HPLC-MS in HILIC mode. Talanta 2019, 205, 120161.
4. Seydlová, G.; Pohl, R.; Zborníková, E.; Ehn, M.; Šimák, O.; Panova, N.; Kolář, M.; Bogdanová, K.; Večeřová, R.; Fišer, R.; Šanderová, H.; Vítovská, D.; Sudzinová, P.; Pospíšil, J.; Benada, O.; Křížek, T.; Sedlák, D.; Bartůněk, P.; Krásný, L.; Rejman, D. Lipophosphonoxins II: Design, Synthesis, and Properties of Novel Broad Spectrum Antibacterial Agents. J. Med. Chem. 2017, 60(14):6098-6118.
3. Beljantseva, J.; Kudrin, P.; Jimmy, J.; Ehn, M.; Pohl, R.; Varik, V.; Tozawa, Y.; Shingler, V.; Tenson, T.; Rejman, D.; Hauryliuk, V. Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor. Sci. Rep., 2017, 41839.
2. Barvík, I.; Rejman, D.; Panova, N.; Šanderová, H.; Krásný, L. Non-canonical transcription initiation: the expanding universe of transcription initiating substrates. FEMS Microbiol. Rev. 2016, fuw041, 1-8. doi: 10.1093/femsre/fuw041.
1. Rejman, D.; Panova, N.; Klener, P.; Maswabi, B.; Pohl, R.; Rosenberg, I. N-Phosphonocarbonylpyrrolidine Derivatives of Guanine: A New Class of Bi-Substrate Inhibitors of Human Purine Nucleoside Phosphorylase. J. Med. Chem. 2012, 55, 1612-1621.